相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimization and qualification of capillary zone electrophoresis method for glycoprotein isoform distribution of erythropoietin for quality control laboratory
Junge Zhang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Strategies for Analysis of the Glycosylation of Proteins: Current Status and Future Perspectives
Susan A. Brooks
MOLECULAR BIOTECHNOLOGY (2009)
The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309
Kearkiat Praditpornsilpa et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL
Brian D. Bradbury et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo)
Esther Llop et al.
ANALYTICAL BIOCHEMISTRY (2008)
Epoetin-associated pure red cell aplasia: past, present, and future considerations
June M. McKoy et al.
TRANSFUSION (2008)
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation
S Hermeling et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Reaction to the paper: Interaction of polysorbate 80 with erythropoietin: A case study in protein-surfactant interactions
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2006)
Immunologic mechanisms of EPO-associated pure red cell aplasia
H Schellekens
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery
K Boven et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients
DJ Cotter et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Erythropoietic proteins and antibody-mediated pure red cell aplasia: a potential role for micelles
H Schellekens
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Micelle-associated protein in epoetin formulations: A risk factor for immunogenicity?
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2003)
Stabilization of human recombinant erythropoietin through interactions with the highly branched N-glycans
T Toyoda et al.
JOURNAL OF BIOCHEMISTRY (2000)
分享论文
